RLAY RELAY THERAPEUTICS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 18 analyst firms say about RELAY THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
18 rated views · 20 analyst/firm records · 18 firms
Radar score
- Russell 2000 · Top Picks · 6MGood · #53 in the index86
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8079
Recent analyst activity · last 90 days
Our tracked history has 7 reports on RLAY from 7 analyst firms in the last 90 days (18 firms in the past year).
Comparing each firm's latest target with its previous one: 3 raised their price target and 1 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: HC Wainwright raised its target from $25.00 (set 29 Apr 2026) to $29.00 on 20 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Etzer Darout | Buy | 7 Aug 2026 | 30.00 USD |
| Canaccord Genuity | John L Newman | Buy | 26 Oct 2026 | 29.00 USD |
| Citigroup | Unnamed analyst | Buy | 10 Aug 2026 | — |
| Citizens JMP | Silvan C Tuerkcan | Buy | 10 Aug 2026 | 26.00 USD |
| Citizens JMP | Silvan Turkcan | Buy | 10 Aug 2026 | 26.00 USD |
| Goldman Sachs | Salveen Richter | Buy | 21 Jul 2026 | 31.00 USD |
| Guggenheim | Brad Canino | Buy | 7 Aug 2026 | — |
| Guggenheim | Michael Schmidt | Buy | 7 Aug 2026 | 26.00 USD |
| H.C. Wainwright | Robert Burns | Buy | 20 Aug 2026 | 29.00 USD |
| Jefferies | Akash Tewari | Buy | 2 Mar 2026 | 32.00 USD |
| Jonestrading | Boris Peaker | Buy | 19 May 2026 | 20.00 USD |
| JPMorgan | Priyanka Grover | Buy | 14 Aug 2026 | 31.00 USD |
| Leerink Partners | Andrew Berens | Buy | 7 Aug 2026 | 26.00 USD |
| Oppenheimer | Matthew Biegler | Buy | 28 Apr 2026 | 18.00 USD |
| Raymond James | Sean Mccutcheon | Buy | 2 Jun 2026 | — |
| TD Cowen | Yaron Werber | Buy | 15 Jun 2026 | — |
| UBS | Unnamed analyst | — | 19 May 2026 | 26.00 USD |
| Weiss Ratings | Unnamed analyst | — | 2 Oct 2026 | — |
| Wells Fargo | Eva Fortea-Verdejo | Buy | 28 Apr 2026 | 21.00 USD |
| Data feed RESEARCH | Research Team | Hold | 20 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:46 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.